Use a joint approach to osteoarthritisJuly 9, 2018As they age, approximately 20 percent of dogs experience osteoarthritis, a condition exacerbated by excess weight as well as by stress on joints from working or performance activities. Breeds such as golden and Labrador retrievers are overrepresented, but degenerative joint disease isn’t limited to highly active dogs or even to old dogs.
SPONSORED CONTENTProtect your patients from the start.Simparica Trio (sarolaner, moxidectin, and pyrantel chewable tablets) is the first monthly preventative of its kind. Combining three ingredients for month-long protection. + Learn more
CE explores expanded treatment options for improving mobility in geriatric petsSeptember 19, 2017Companion Animal Health has opened enrollment for an educational course that the company said is "designed specifically to give general veterinary practices access to the tools required to meet the need for expanded osteoarthritis treatment options in companion animals" and "will equip practices with the practical knowledge of the best multimodal approaches for successfully managing the geriatric, arthritic, and obese dog and/or cat." Attendees will earn 11 continuing education credits, with the option of adding a regenerative medicine wet-lab to advance their expertise (for an additional four CE credits). A panel of speakers will educate attendees on the following topics: Nutritional Management for the Geriatric Dog or Cat Photobiomodulation (Laser Therapy) for OA Nutriceutical Use for the Geriatric, Arthritic Pet Pharmacologic Management of OA Business & Marketing Strategies "We took a look at what courses were being offered in our profession currently, and there weren't really any that combined more than one or two OA treatment options," said Lisa Miller, DVM, CCRT, CVA. "This disease responds best to a multimodal approach, so we designed a course to accommodate that need." Veterinary professionals interested in attending this course can find more information on dates, …
Veterinary oncology market profiled in new Brakke Consulting reportSeptember 15, 2017Brakke Consulting in Dallas has announced the release of a new study that profiles the veterinary oncology sector. "Oncology is one of the highest interest areas in veterinary medicine today," said Lynn Fondon DVM, a senior consultant at Brakke Consulting. "In the past decade, the U.S. has gone from zero cancer therapies approved for veterinary use to a more than a half-dozen, with dozens more in development." The study, Cancer in Dogs and Cats, provides information on the incidence of cancer in pets, examines how cancer is diagnosed and treated in veterinary medicine, and offers estimated costs for treatment. The report reviews the FDA-approved cancer treatments that are now on the market; new and developing veterinary cancer products, including therapies, diagnostics, and supportive care, are also presented. It estimates the current sales of veterinary-approved cancer therapies, as well as provides estimates of the total number of pets treated with chemotherapy or immunotherapy. "We surveyed both veterinarians and pet owners for this study, and we found that despite costs that can reach thousands of dollars, many dog and cat owners are willing to pursue treatment when their pets are diagnosed with cancer," said Dr. Fondon. The report, …
American Association of Feline Practitioners revises declawing positionSeptember 7, 2017The American Association of Feline Practitioners (AAFP) has revised its previous 2015 position statement on declawing to strongly oppose onychectomy as an elective procedure.
